Tumor-Killing Liquid Offers A Safer "Bridge" Therapy for Patients with Liver Cancer (3 of 3) (IMAGE)

American Association for the Advancement of Science (AAAS)

Tumor-Killing Liquid Offers A Safer "Bridge" Therapy for Patients with Liver Cancer (3 of 3)

Caption

A microCT image of an explanted rabbit liver injected with LATTE (mixed with a contrast agent) in the tumor zone. This material relates to a paper that appeared in the Jan. 20, 2021, issue of <i>Science Translational Medicine</i>, published by AAAS. The paper, by H. Albadawi at Mayo Clinic in Phoenix, AZ; and colleagues was titled, "Percutaneous liquid ablation agent for tumor treatment and drug delivery."

Credit

[Credit: H. Albadawi <i>et al., Science Translational Medicine</i> (2021)]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.